Cell Isolation Market To Witness Growth Based On Increasing Demand For Personalized Medicine Till 2025:Grand View Research,inc.
The global cell isolation/cell separation market is expected
to reach a value of USD 16.4 billion by 2025, according to a new report by
Grand View Research, Inc. Increasing demand for biopharmaceuticals including
antibodies, proteins, vaccines, and drugs is the most important factor that
drives the market growth during the forecast period. Biopharmaceuticals
development involves the application of various life science products such as
centrifuges, cell separator systems, flow cytometers, filtration systems, and
consumables. Thus, the demand for advanced cell isolation products by
biotechnology and biopharmaceutical companies is increasing, which is expected
to boost the market growth.
Rising funding by biotechnology
companies and government for cell-based research is another major factor
driving the growth of the cell isolation/cell separation market. For instance,
National Institutes of Health invested around USD 1,429 million for stem cells
research in 2015. Stem cell therapy is the most promising technique to treat
severe medical conditions such as cancer, cardiovascular disease, brain
disease, and blood disease. Thus, the biotechnology companies are adopting
advanced cell separation products for the research and development of stem
cells.
U.S. cell isolation market, by product, 2014 - 2025 (USD
Million)
Browse full research report on
Cell
Isolation Market Analysis:
Further key findings from the report suggest:
- Consumables
product segment was the largest revenue-generating segment of the market
in the year 2016.
- Consumables
is expected to uphold its dominance during the forecast period owing to
repetitive purchase of these products for research and diagnostics
application
- The human
cells segment was the largest revenue grossing segment of the sector in
2016, and is expected to grow at fastest rate due to growing demand of
isolated human cell in therapeutics, research, and biopharmaceuticals
production
- In 2016, the
centrifugation technique segment accounted for the largest share in the
overall market, owing to its wide application for manufacturing of
biopharmaceutical drugs, vaccines, proteins, and antibodies
- In 2016,
North America dominated the overall market with the largest revenue share
due to the existence of major biopharmaceutical companies and research
laboratories in this region
- Asia Pacific
is projected to witness the highest CAGR over the forecast period, owing
to the mounting investments in cell-based research and rapidly booming
biotechnology industry in this region
- Some of the
key players include Thermo Fisher Scientific, Inc.; BD Biosciences; GE
Healthcare; Beckman Coulter, Inc.; Merck KGaA; Terumo BCT; STEMCELL
Technologies Inc.; and Bio-Rad Laboratories, Inc.
For
more information: http://www.grandviewresearch.com
Comments
Post a Comment